Home » Topics » Regulatory

Regulatory
RSS

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

Feb. 6, 1998

Zestril introduced for new indication in U.K.

Feb. 5, 1998

Avita gel can now be launched in U.S.

Feb. 5, 1998

Tiazac approved for angina in U.S.

Feb. 5, 1998

Asacard approved in U.K.

Feb. 4, 1998

New formulation of enalapril now available in U.K.

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Crescendo and Alza to collaborate on chronic pain product

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...